Skip to content
Saturday, March 15, 2025
GLP-1 Watch
All the latest news and updates about GLP-1 Drugs
Search
Search
Privacy Policy
The Evolving Landscape of GLP-1 Drugs: Innovations, Market Trends, and Health Implications
Home
2025
March
7
UK’s pricing watchdog rejects Alzheimer treatments for the second time
GLP-1 News
UK’s pricing watchdog rejects Alzheimer treatments for the second time
March 7, 2025
admin
NICE previously rejected Leqembi and Kisunla for NHS coverage in August and October 2024, respectively.
Post navigation
J&J drops Phase III MDD programme due to lack of efficacy
US judge denies injunction, restricting copies of Lilly weight-loss drug – Reuters